Navigation Links
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
Date:10/5/2007

DETROIT, Oct. 5 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd., (Amex: CPD) announced today that the US Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Cetirizine Hydrochloride Chewable Tablets, 5 mg and 10 mg (Cetirizine HCl Chewable). Final approval to market this product is anticipated subsequent to the expiry of patent protection on December 25, 2007.

Cetirizine HCl Chewable is indicated for the relief of symptoms associated with seasonal allergic rhinitis due to allergens in adults and children 2 years of age and older; perennial allergic rhinitis in adults and children 6 months of age and older; and for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. This tentative approval is the bioequivalent to Zyrtec Chewable(R), a registered trademark of Pfizer, Inc. Zyrtec Chewable(R) tablets had U.S. sales of approximately $75 million for the 12-month period ended June 30, 2007, according to IMS Data.

Daniel H. Movens, Caraco's Chief Executive Officer, said, "We are extremely pleased to receive this tentative approval and look forward to the expiration date of the patent on December 25, 2007, which will allow Caraco to market the product. We feel that Cetirizine HCl Chewable complements our previously announced FDA tentative approval of Cetirizine Hydrochloride Immediate Release Tablets, 5 mg and 10 mg, and both products will be positive additions to our portfolio by expanding our product offerings."

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic and priva
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...e likely to miscarrry after IVF treatment- but los... say doctors. They are urging overweight women to ...mbarking on fertilty treatments. Obese women have ...s conceiving naturally, and studies have shown tha...
...contained mechanical heart has been implanted and ... hour operation, a US hospital has announced. The ... in the development of an artificial replacement h...ul, the device could help thousands of patients wh...
...lp of fertility treatment grow into emotionally an...w research. The world's first study that followed ...lescence showed that youngsters who had been conce...ts do not suffer any more psychological problems t...
... remains a therapeutic challenge for many practisi...ms of medicine has taken its stride. Acupuncture v...d with some practitioners. Dr. Dominik Irnich of L...as done a study on this basis and found that when ...
Other Medicine News:
(Date:9/3/2008)...m chronically infected Hepatitis C,patients strong...er in 2008, - Study is the first to show a stati...l effect of therapeutic Hepatitis C vaccination, ...o a second generation, vaccine formulated with In... activation, VIENNA, Aus...
(Date:9/3/2008)... (dronedarone) decreased the risk of,stroke by 34%...tter already adequately treated by an.../- The results of a,post-ho...presented today at,the clinical trial update sessi...2008, in Munich, Germany. Previous results from th...
(Date:9/3/2008)...-Dosing Study in Subjects with ALS, RICHMOND, Cal...Sciences, Inc. (Nasdaq: SGMO ) announced today th...801) to evaluate its drug, SB-509, in subjects,wit...sease for which there,are limited treatment option...ectable formulation of a plasmid,encoding a zinc f...
(Date:9/2/2008)...ONE to Build Hope and Give Help, MINNEAPOLIS, Sep...epublican Party Convention are sending a message t... including evacuees in the Gulf Coast region,and t...ntries: "We are here,to help.", World Vision and ...o,something unconventional. This event provides an...
Breaking Medicine Technology:Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 2Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 3Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 4The Valley Hospital in Ridgewood NJ Announces Historic 2430 Million Gift 21926 1The Valley Hospital in Ridgewood NJ Announces Historic 2430 Million Gift 21926 2Harvard Study in Joint Commission Journal 3A Mortality Rates Lower in Leapfrog Hospitals 21922 1Harvard Study in Joint Commission Journal 3A Mortality Rates Lower in Leapfrog Hospitals 21922 2Harvard Study in Joint Commission Journal 3A Mortality Rates Lower in Leapfrog Hospitals 21922 3Celator 28R 29 Pharmaceuticals to Present at 2008 BIO International Convention 6007 1Test of bacteria toxin delivery system could pave way for new antibiotic drugs 3646 1Test of bacteria toxin delivery system could pave way for new antibiotic drugs 3646 2
...r , Some form of electronic hematology analy...tories. A blood cell count is usually the first sc...ut anemia or infection, and monitor cancer patient...lt to imagine medical care without this workhorse ... Early testing of sonar, developed to detect subma...
...ting Editor , ,Positive patient identificatio...dies for the past few years. Until recently, the ...eyond the reach of the average hospital or laborat...s that can be integrated into a facilitys IS requi...all facilities, while others are best for larger i...
Other Medicine Technology:Hematology Analyzers Simple, Sophisticated Technology Serving All Patients 2Hematology Analyzers Simple, Sophisticated Technology Serving All Patients 3Managing Preanalytical Processes for Patient Safety 2Managing Preanalytical Processes for Patient Safety 3Managing Preanalytical Processes for Patient Safety 4
...ment introduction. The design of the introducer fe...ition profile between the introducer sheath and in...h fascial tissue and strictured areas. Proximal re...ducer sheath and introducer dilator during sheath ...
Used for catheter or instrument introduction. The dual knobs allow the sheath to be peeled away and removed. The maximum diameter of the catheter or instrument to be introduced should be measured to
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use.
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: